Risperidone Lawsuit – Gynecomastia – Breast Growth in Boys.
We are a national law firm and represent clients across the U.S. Risperdal lawsuits are being filed in Philadelphia where CQH Firm is based.
Risperdal has been at the center of numerous Risperdal gynecomastia lawsuits involving child and adolescent males. Gynecomastia is a serious medical condition that causes male patients to develop or grow breasts. The cases against Johnson & Johnson allege that the drug Risperdal causes the hormone prolactin to increase at high rates, stimulating breast development. Claudine Q. Homolash was trial counsel on the 3rd Risperdal trial in 2012 against J&J. The CQH Firm is investigating Risperdal gynecomastia lawsuits on behalf of boys who have developed male breasts, or gynecomastia due to Risperdal or Risperidone manufactured by Patriot Pharmaceuticals.
Please call 1-(844) 677-4276 or (215) 496-1012 for a free Risperdal gynecomastia lawsuit evaluation or fill out our free Risperdal consultation form.
If your child has developed breasts while taking Risperdal you may be eligible for financial compensation.
Risperidone, manufactured by Johnson & Johnson and sold as Risperdal, is a second generation atypical antipsychotic drug that was first approved by the U.S. Food and Drug Administration (FDA) in 1993, and is used as a treatment for schizophrenia, mania, and irritability associated with autistic disorder in children and teenagers.
CQH Firm represents boys who suffered abnormal breast growth. The lawsuits allege that J&J failed to warn physicians and patients about the increased risk of gynecomastia, especially in young, developing boys. Some of the victims have been forced to undergo mastectomies because of the size of their breasts.
One lawsuit, which was filed in Philadelphia, involved a 21-year-old man who alleged that a Risperdal side effect caused him to develop breasts after he took the drug for about five years starting at the age of nine. The man said in the complaint that he suffered psychological trauma because of the Risperdal breast growth side effects of the drug and had to have his breasts surgically removed. In September 2012, J&J settled that case under confidential terms just as the trial was about to begin. Hundreds of Risperdal gynecomastia, male breast growth, lawsuits have been reportedly filed against J&J and its subsidiary Janssen. Claudine Homolash was co-counsel on this case.
Johnson & Johnson Settles Whistleblower Case Involving Risperdal
On November 4, 2013, the federal government announced that Johnson & Johnson agreed to pay more than $2.2 billion to resolve fraud and misbranding allegations related to the marketing of its drug Risperdal. Of the $2.2 billion, J&J is paying $1.673 billion to resolve allegations of off-label marketing for Risperdal and Invega, as well as the alleged payment of kickbacks to physicians involving Risperdal. The resolution – the largest in U.S. history involving a single drug (Risperdal) and the third-largest health care fraud settlement involving one company.
Lawsuits in Philadelphia
The CQH Firm represents people from across the country who have been injured by Risperdal. Risperdal lawsuits are being filed in Philadelphia, where CQH Firm is based.
Let a Philadelphia Lawyer help you. Call 1-800-975-8834 for a free Risperdal gynecomastia consultation.